Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

OBJECTIVE: The investigation regarding the clinical significance of quantitative hepatitis B core antibody (anti-HBc) during chronic hepatitis B (CHB) treatment is limited. The aim of this study was to determine the performance of anti-HBc as a predictor for hepatitis B e antigen (HBeAg) seroconvers...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Gut
Autori principali: Fan, Rong, Sun, Jian, Yuan, Quan, Xie, Qing, Bai, Xuefan, Ning, Qin, Cheng, Jun, Yu, Yanyan, Niu, Junqi, Shi, Guangfeng, Wang, Hao, Tan, Deming, Wan, Mobin, Chen, Shijun, Xu, Min, Chen, Xinyue, Tang, Hong, Sheng, Jifang, Lu, Fengmin, Jia, Jidong, Zhuang, Hui, Xia, Ningshao, Hou, Jinlin
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2016
Soggetti:
Hepatology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4752655/
https://ncbi.nlm.nih.gov/pubmed/25586058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2014-308546
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi